Skip to Content
Learn about Amitiza, a treatment of Chronic Constipation

Drug interactions between MiraLax and Movantik

Results for the following 2 drugs:
MiraLax (polyethylene glycol 3350)
Movantik (naloxegol)

Interactions between your drugs

There were no interactions found in our database between MiraLax and Movantik - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

MiraLax

A total of 255 drugs (898 brand and generic names) are known to interact with MiraLax.

Movantik

A total of 192 drugs (676 brand and generic names) are known to interact with Movantik.

Drug and food interactions

Major

naloxegol food

Applies to: Movantik (naloxegol)

Do not consume grapefruit or grapefruit juice during treatment with naloxegol. Grapefruit juice can significantly increase the blood levels of naloxegol. You may be more likely to experience side effects and withdrawal symptoms such as sweating, tearing, runny nose, chills, diarrhea, abdominal pain, anxiety, insomnia, irritability, restlessness, and yawning. Taking naloxegol with food can also increase its absorption into the blood stream. Therefore, you should take it on an empty stomach at least 1 hour before or 2 hours after a meal. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No therapeutic duplications were found for your selected drugs.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide